GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $43,523,000 | +5961.7% | 639,097 | +3529.2% | 0.20% | +6633.3% |
| Q1 2021 | $718,000 | -78.8% | 17,610 | -77.5% | 0.00% | -80.0% |
| Q4 2020 | $3,385,000 | +33.2% | 78,153 | +69.5% | 0.02% | +50.0% |
| Q3 2020 | $2,542,000 | -47.3% | 46,101 | -39.6% | 0.01% | -58.3% |
| Q2 2020 | $4,820,000 | +883.7% | 76,357 | +695.4% | 0.02% | +700.0% |
| Q1 2020 | $490,000 | -62.8% | 9,600 | -42.0% | 0.00% | -25.0% |
| Q4 2019 | $1,317,000 | -50.7% | 16,565 | -69.9% | 0.00% | -60.0% |
| Q3 2019 | $2,671,000 | +29.8% | 55,053 | +41.6% | 0.01% | +25.0% |
| Q1 2019 | $2,058,000 | +586.0% | 38,887 | +392.2% | 0.01% | +700.0% |
| Q3 2018 | $300,000 | -25.6% | 7,901 | -11.5% | 0.00% | -50.0% |
| Q2 2018 | $403,000 | -71.3% | 8,928 | -69.2% | 0.00% | -66.7% |
| Q1 2018 | $1,402,000 | – | 29,022 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |